Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'
Companies, agencies, institutions, etc
National Institute of Allergy
the Food and Drug Administration’s
MSNBC
Omicron
Delta
FDA
Twitter @MagnifiTrentClipsHealthScienceAnthony
FaucicoronavirusJosé Díaz-Balart ReportsMonoclonal
People
Anthony Fauci
José Díaz-Balart
GSK.”Follow Trent Baker
Breitbart
Groups
No matching tags
Physical locations
Delta
Places
No matching tags
Locations
the United States
Events
No matching tags
Summary
National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci on Tuesday defended the?Food and Drug Administration's decision to rescind emergency-use authorizations for?two monoclonal treatments used for the coronavirus. | Clips
As said here by Trent Baker